title: Influence of bevacizumab on vaginal cuff evisceration eight months after ovarian cancer cytoreduction surgery: A case report.
abstract: •44 year old woman treated with bevacizumab for metastatic epithelial ovarian cancer•The patient experienced vaginal cuff dehiscence and evisceration at 8 months post-operatively.•Metastasis at the surgical site and chronic inflammation implicated.
authors.affiliation: Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA, USA.
authors.forename: Amanda J
authors.initials: AJ
authors.lastname: Skwara
authors.affiliation: Department of Medical Oncology, Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA, USA ; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA, USA.
authors.forename: Russell J
authors.initials: RJ
authors.lastname: Schilder
authors.affiliation: Department of Medical Oncology, Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA, USA.
authors.forename: Allison
authors.initials: A
authors.lastname: Zibelli
authors.affiliation: Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Jefferson Medical College of Thomas Jefferson University, Philadelphia, PA, USA.
authors.forename: Norman G
authors.initials: NG
authors.lastname: Rosenblum
keywords: Bevacizumab; Delayed evisceration; Epithelial ovarian cancer